Skip to content
OpenCapital
Get started

Geospace Technologies Corporation GEOS Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$19.7M+9.5%
Gross profit$694.0K-60.3%
Operating income-$11.4M-11.1%
Net income-$11.0M-12.8%
EPS (diluted)-$0.86-11.7%

Balance sheet

See full
Cash & equivalents$13.4M+61.1%
Total debt$769.0K+93.7%
Total equity$105.1M-21.0%
Total assets$136.7M-8.2%

Cash flow

See full
Operating cash flow-$1.6M+16.0%
CapEx$535.0K-56.1%
Free cash flow-$2.1M+31.7%

Valuation

See full
Market cap$87.57M-57.4%
Enterprise value$74.99M-58.9%
P/S0.9×-0.9×

Profitability

See full
Gross margin38.8%—
Operating margin5.2%—
Net margin-2%—
FCF margin-17.6%—

Returns & leverage

See full
Return on equity-1.7%—
Debt / equity0×0.0×
Current ratio2.5×-3.1×